1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX

NCT01692626 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Interim analysis shows no efficacy

Conditions

Rash

Interventions

DRUG: Pimecrolimus
DRUG: Placebo

Sponsor

West Virginia University